Yu-Fang Huang

2025

Fistula formation after excision of extraperitoneal paravaginal teratoma

Lin, T. C., Chen, P-C., Liu, W-S-C., Chiang, C. T. & Huang, Y. F., 2025 1月, 於: Taiwanese Journal of Obstetrics and Gynecology. 64, 1, p. 151-154 4 p.

研究成果: Article › 同行評審

開啟存取

2023

Desmoid-type fibromatosis mimicking uterine fibroid invade the urinary bladder: A case report and literature review

Hung, Y. T., Huang, Y. F. & Wu, P. Y., 2023 1月, 於: Taiwanese Journal of Obstetrics and Gynecology. 62, 1, p. 158-162 5 p.

研究成果: Article › 同行評審

開啟存取

The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells

Wu, Y. H., Huang, Y. F., Wu, P. Y., Chang, T. H., Huang, S. C. & Chou, C. Y., 2023 12月, 於: Journal of Ovarian Research. 16, 1, 124.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

2022

Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study

Chou, C. Y., Cheng, W. F., Chen, M. Y., Lin, H., Ho, C. M., Hung, Y. C., Huang, L. W., Wang, P. H., Yu, M. H. & Huang, Y. F., 2022 4月 1, 於: Cancers. 14, 7, 1746.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

2021

COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells

Wu, Y. H., Huang, Y. F., Chang, T. H., Chen, C. C., Wu, P. Y., Huang, S. C. & Chou, C. Y., 2021 7月 1, 於: Oncogene. 40, 26, p. 4503-4519 17 p.

研究成果: Article › 同行評審

54 引文斯高帕斯（Scopus）

Mir-335 restrains the aggressive phenotypes of ovarian cancer cells by inhibiting col11a1

Wu, Y. H., Huang, Y. F., Chang, T. H., Wu, P. Y., Hsieh, T. Y., Hsiao, S. Y., Huang, S. C. & Chou, C. Y., 2021 12月 1, 於: Cancers. 13, 24, 6257.

研究成果: Article › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

2020

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

Wu, Y. H., Huang, Y. F., Chen, C. C., Huang, C. Y. & Chou, C. Y., 2020 3月 3, 於: Frontiers in Pharmacology. 11, 206.

研究成果: Article › 同行評審

開啟存取

36 引文斯高帕斯（Scopus）

Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience

Wu, P. Y., Cheng, Y. M., Shen, M. R., Chen, Y. C., Huang, Y. F. & Chou, C. Y., 2020 7月 14, 於: Frontiers in Oncology. 10, 1095.

研究成果: Article › 同行評審

開啟存取

10 引文斯高帕斯（Scopus）

2019

A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial Ovarian, Tubal, and peritoneal cancer within 12 months after platinum-based Chemotherapy

Huang, Y. F., Kuo, M. T., Liu, Y. S., Cheng, Y. M., Wu, P. Y. & Chou, C. Y., 2019, 於: Frontiers in Oncology. 9, MAY, 437.

研究成果: Article › 同行評審

開啟存取

27 引文斯高帕斯（Scopus）

Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression

Wu, Y. H., Huang, Y. F., Chen, C. C. & Chou, C. Y., 2019 4月 1, 於: Cell Death and Disease. 10, 4, 322.

研究成果: Article › 同行評審

開啟存取

40 引文斯高帕斯（Scopus）

2018

Vitamin D–binding protein enhances epithelial ovarian cancer progression by regulating the insulin-like growth factor-1/akt pathway and Vitamin D receptor transcription

Huang, Y. F., Wu, Y. H., Cheng, W. F., Peng, S. L., Shen, W. L. & Chou, C. Y., 2018 7月 1, 於: Clinical Cancer Research. 24, 13, p. 3217-3228 12 p.

研究成果: Article › 同行評審

開啟存取

9 引文斯高帕斯（Scopus）

2017

Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression

Wu, Y. H., Huang, Y. F., Chang, T. H. & Chou, C. Y., 2017 12月 1, 於: International Journal of Cancer. 141, 11, p. 2305-2317 13 p.

研究成果: Article › 同行評審

開啟存取

56 引文斯高帕斯（Scopus）

Case report: Term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix

Wu, P. Y., Cheng, Y. M., New, G. H., Chou, C. Y., Chiang, C. T., Tsai, H. W. & Huang, Y. F., 2017 7月 28, 於: BMC Women's Health. 17, 1, 56.

研究成果: Article › 同行評審

開啟存取

14 引文斯高帕斯（Scopus）

Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A taiwanese gynecologic oncology group (TGOG) study

Chiang, A. J., Chen, M. Y., Weng, C. S., Lin, H., Lu, C. H., Wang, P. H., Huang, Y. F., Chiang, Y. C., Yu, M. H. & Chang, C. L., 2017 9月, 於: Journal of Gynecologic Oncology. 28, 5

研究成果: Article › 同行評審

開啟存取

45 引文斯高帕斯（Scopus）

2016

Seeking new surgical predictors of mesh exposure after transvaginal mesh repair

Wu, P. Y., Chang, C. H., Shen, M. R., Chou, C. Y., Yang, Y. C. & Huang, Y. F., 2016 10月 1, 於: International Urogynecology Journal. 27, 10, p. 1547-1555 9 p.

研究成果: Article › 同行評審

8 引文斯高帕斯（Scopus）

2015

COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPß pathway and PDK1 stabilization

Wu, Y. H., Chang, T. H., Huang, Y. F., Chen, C. C. & Chou, C. Y., 2015, 於: Oncotarget. 6, 27, p. 23748-23763 16 p.

研究成果: Article › 同行評審

開啟存取

83 引文斯高帕斯（Scopus）

Current state of evidence-based practice education for undergraduate nursing students in Taiwan: A questionnaire study

Hung, H. Y., Huang, Y. F., Tsai, J. J. & Chang, Y. J., 2015 12月, 於: Nurse Education Today. 35, 12, p. 1262-1267 6 p.

研究成果: Article › 同行評審

33 引文斯高帕斯（Scopus）

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells

Chiu, W. T., Huang, Y. F., Tsai, H. Y., Chen, C. C., Chang, C. H., Huang, S. C., Hsu, K. F. & Chou, C. Y., 2015, 於: Oncotarget. 6, 4, p. 2349-2365 17 p.

研究成果: Article › 同行評審

開啟存取

120 引文斯高帕斯（Scopus）

Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer

Hsu, K. F., Shen, M. R., Huang, Y. F., Cheng, Y. M., Lin, S. H., Chow, N. H., Cheng, S. W., Chou, C. Y. & Ho, C. L., 2015 7月 28, 於: British Journal of Cancer. 113, 3, p. 414-424 11 p.

研究成果: Article › 同行評審

開啟存取

93 引文斯高帕斯（Scopus）

Solanum incanum extract downregulates aldehyde dehydrogenase 1-mediated stemness and inhibits tumor formation in ovarian cancer cells

Wu, Y. H., Chiu, W. T., Young, M. J., Chang, T. H., Huang, Y. F. & Chou, C. Y., 2015, 於: Journal of Cancer. 6, 10, p. 1011-1019 9 p.

研究成果: Article › 同行評審

開啟存取

28 引文斯高帕斯（Scopus）

2014

All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells

Young, M. J., Wu, Y. H., Chiu, W. T., Weng, T. Y., Huang, Y. F. & Chou, C. Y., 2014 7月 10, 於: Carcinogenesis. 36, 4, p. 498-507 10 p.

研究成果: Article › 同行評審

開啟存取

61 引文斯高帕斯（Scopus）

Cell fate regulation by gelsolin in human gynecologic cancers

Abedini, M. R., Wang, P. W., Huang, Y. F., Cao, M., Chou, C. Y., Shieh, D. B. & Tsang, B. K., 2014 10月 7, 於: Proceedings of the National Academy of Sciences of the United States of America. 111, 40, p. 14442-14447 6 p.

研究成果: Article › 同行評審

開啟存取

50 引文斯高帕斯（Scopus）

Circulating IGF system and treatment outcome in epithelial ovarian cancer

Huang, Y. F., Cheng, W. F., Wu, Y. P., Cheng, Y. M., Hsu, K. F. & Chou, C. Y., 2014 4月, 於: Endocrine-Related Cancer. 21, 2, p. 217-229 13 p.

研究成果: Article › 同行評審

開啟存取

41 引文斯高帕斯（Scopus）

COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer

Wu, Y. H., Chang, T. H., Huang, Y. F., Huang, H. D. & Chou, C. Y., 2014 6月 26, 於: Oncogene. 33, 26, p. 3432-3440 9 p.

研究成果: Article › 同行評審

開啟存取

152 引文斯高帕斯（Scopus）

Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study

Chen, C. A., Lin, H., Weng, C. S., Wen, K. C., Lu, C. H., Chou, H. H., Huang, Y. F., Kang, C. Y., Ho, C. M., Yu, M. H. & Chou, C. Y., 2014 12月, 於: European Journal of Cancer. 50, 18, p. 3161-3167 7 p.

研究成果: Article › 同行評審

9 引文斯高帕斯（Scopus）

Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: A Taiwanese Gynecologic Oncology Group study

Lu, C. H., Chen, I. H., Chen, Y. J., Wang, K. L., Qiu, J. T. T., Lin, H., Lin, W. C., Liou, W. S., Huang, Y. F., Lin, Y. S., Tee, Y. T. & Hung, Y. C., 2014 3月, 於: International Journal of Gynecological Cancer. 24, 3, p. 506-512 7 p.

研究成果: Article › 同行評審

開啟存取

13 引文斯高帕斯（Scopus）

2013

Three-dimensional power Doppler ultrasound in cervical carcinoma: Monitoring treatment response to radiotherapy

Huang, Y. F., Cheng, Y. M., Wu, Y. P., Chen, H. H. W., Hsu, K. F., Wu, Y. H. & Chou, C. Y., 2013 7月, 於: Ultrasound in Obstetrics and Gynecology. 42, 1, p. 84-92 9 p.

研究成果: Article › 同行評審

開啟存取

12 引文斯高帕斯（Scopus）

2012

Brain metastases from epithelial ovarian carcinoma: Evaluation of prognosis and managements - A Taiwanese Gynecologic Oncology Group (TGOG) Study

Chiang, Y. C., Qiu, J. T., Chang, C. L., Wang, P. H., Ho, C. M., Lin, W. C., Huang, Y. F., Lin, H., Lu, C. H. & Chou, C. Y., 2012 4月, 於: Gynecologic oncology. 125, 1, p. 37-41 5 p.

研究成果: Article › 同行評審